HomeCompanies › ETON

Eton Pharmaceuticals, Inc.

Most recent annual filing: 2026-03-15

Pipeline (14 active programs)

ET-700

  • Undisclosed indication

hydrocortisone

ET-800
  • Undisclosed indication intravenous

KHINDIVI

  • Undisclosed indication

Biotech Distilled coverage (7)

Articles open on Substack. Some deep dives are subscriber-only.